The conformational variant of p53, detected by 2D3A8 and then quantified by mass spectroscopy (identified as U-p53AZ), was further validated as a potential prognostic biomarker in AD in a set of plasma samples from the longitudinal and retrospective biobank, AIBL (Piccirella et al., 2021). The gene discussed is TP53; the disease is Alzheimer disease.